417 related articles for article (PubMed ID: 21200319)
21. Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
Souweine B; Lautrette A; Gruson D; Canet E; Klouche K; Argaud L; Bohe J; Garrouste-Orgeas M; Mariat C; Vincent F; Cayot S; Cointault O; Lepape A; Guelon D; Darmon M; Vesin A; Caillot N; Schwebel C; Boyer A; Azoulay E; Bouadma L; Timsit JF
Am J Respir Crit Care Med; 2015 May; 191(9):1024-32. PubMed ID: 25668557
[TBL] [Abstract][Full Text] [Related]
22. Cloxacillin as an antibiotic lock solution for prevention of catheter-associated infection.
Davanipur M; Pakfetrat M; Roozbeh J
Iran J Kidney Dis; 2011 Sep; 5(5):328-31. PubMed ID: 21876310
[TBL] [Abstract][Full Text] [Related]
23. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
[TBL] [Abstract][Full Text] [Related]
24. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Betjes MG; van Agteren M
Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
[TBL] [Abstract][Full Text] [Related]
25. Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia.
Winnett G; Nolan J; Miller M; Ashman N
Nephrol Dial Transplant; 2008 Nov; 23(11):3592-8. PubMed ID: 18503094
[TBL] [Abstract][Full Text] [Related]
26. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
Yon CK; Low CL
Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of preventing hemodialysis catheter infections with citrate lock.
Silva J; Antunes J; Carvalho T; Ponce P
Hemodial Int; 2012 Oct; 16(4):545-52. PubMed ID: 22515732
[TBL] [Abstract][Full Text] [Related]
28. Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).
Correa Barcellos F; Pereira Nunes B; Jorge Valle L; Lopes T; Orlando B; Scherer C; Nunes M; Araújo Duarte G; Böhlke M
Infection; 2017 Apr; 45(2):139-145. PubMed ID: 27573387
[TBL] [Abstract][Full Text] [Related]
29. Catheter outcomes in the short-term inpatient setting: a controlled quality improvement study comparing citrate and heparin lock.
Parikh S; Nijmeh R; Van Cleef S; Timmerman S; Bhatt UY; Agarwal AK
Semin Dial; 2012 May; 25(3):351-6. PubMed ID: 22074231
[TBL] [Abstract][Full Text] [Related]
30. Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.
Solomon LR; Cheesbrough JS; Bhargava R; Mitsides N; Heap M; Green G; Diggle P
Semin Dial; 2012; 25(2):233-8. PubMed ID: 21916999
[TBL] [Abstract][Full Text] [Related]
31. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.
Filippi L; Pezzati M; Di Amario S; Poggi C; Pecile P
Pediatr Crit Care Med; 2007 Nov; 8(6):556-62. PubMed ID: 17914310
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials.
Zacharioudakis IM; Zervou FN; Arvanitis M; Ziakas PD; Mermel LA; Mylonakis E
Clin Infect Dis; 2014 Dec; 59(12):1741-9. PubMed ID: 25156111
[TBL] [Abstract][Full Text] [Related]
33. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
[TBL] [Abstract][Full Text] [Related]
35. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
Moran JE; Ash SR;
Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
[TBL] [Abstract][Full Text] [Related]
36. Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap.
Hymes JL; Mooney A; Van Zandt C; Lynch L; Ziebol R; Killion D
Am J Kidney Dis; 2017 Feb; 69(2):220-227. PubMed ID: 27839894
[TBL] [Abstract][Full Text] [Related]
37. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
Schallom ME; Prentice D; Sona C; Micek ST; Skrupky LP
Crit Care Med; 2012 Jun; 40(6):1820-6. PubMed ID: 22488006
[TBL] [Abstract][Full Text] [Related]
38. Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study.
Agarwal AK; Roy-Chaudhury P; Mounts P; Hurlburt E; Pfaffle A; Poggio EC
Clin J Am Soc Nephrol; 2023 Nov; 18(11):1446-1455. PubMed ID: 37678222
[TBL] [Abstract][Full Text] [Related]
39. Hemodialysis catheters with citrate locking in critically ill patients with acute kidney injury treated with intermittent online hemofiltration or hemodialysis.
Skofic N; Buturović-Ponikvar J; Kovac J; Premru V; Knap B; Marn Pernat A; Kersnic B; Gubensek J; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):327-33. PubMed ID: 19695069
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection.
Jaffer Y; Selby NM; Taal MW; Fluck RJ; McIntyre CW
Am J Kidney Dis; 2008 Feb; 51(2):233-41. PubMed ID: 18215701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
